Acousia Therapeutics GmbH
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Acousia Therapeutics GmbH
The German biotech plans to prevent chemotherapy-induced hearing loss and treat chronic hearing loss by targeting a potassium channel in the ear’s sensory hair cells as it tackles a widespread but side-lined area.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.